Search results

The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

After careful selection, three Australian science teachers are set to fly to Geneva today after winning positions on the International High School Teacher Programme at CERN.

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.

There is chemistry at work to help us enjoy the New Year's Eve celebration.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

Technical information on the SAXS / WAXS beamline at the Australian Synchrotron.

You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee. 

Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.

Supporting healthcare professionals in Australia with easy-to-access resources related to ANSTO’s Gentech® Generator.

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

A long-standing collaboration led biomedical researchers from the University of Sydney has recently achieved success with the recent announcement of an innovative bone implant that significantly reduces rejection and inflammation.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.